The twin designations are designed to speed up the development and review of promising medicines targeting serious conditions with high unmet need
The agreement could rise to $900 million if key commercial milestones are met
The Danish biotech company confirmed the global study will begin in the second half of 2026
Health innovations are viewed more positively than food and agricultural technologies
The medtech firm strengthens its full-stack remote cardiac monitoring platform, achieves 11x revenue growth, and advances its global expansion plans
New medical and wellness centre combines on-site care with telehealth to support industrial workforce and surrounding communities
Union health minister urges graduates in Chandigarh to combine technological excellence with compassion in medical practice
Backed by ARCHIMED, the deal strengthens connected cardiac diagnostics with integrated Holter, ABPM, and telemedicine solutions
Our company remains focused on advancing monoclonal antibody therapeutics for solid tumors, with a clear emphasis on combination immunotherapy strategies
The initiative is designed to benefit patients as well as healthcare providers by streamlining access to consultations, diagnostics, and essential care services
Subscribe To Our Newsletter & Stay Updated
